EUVIMEDEUVIMED entdecken
Crossref

Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing Lung Adenocarcinoma and Benign Pulmonary Nodules

Xue Zhang, Longtao Ji, Man Liu, Jiaqi Li, Hao Sun, Feifei Liang, Yutong Zhao, Zhi Wang, Ting Yang, Yulin Wang, Qiufang Si, Renle Du und 2 weitere

Journal of Proteome Research · 2024

DOI: 10.1021/acs.jproteome.3c00551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2024. Verfasst von Xue Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Sleep Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052 Henan, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Multiple Pulmonary Nodules. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, Leading Talents of Science and Technology Innovation in Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the pressing clinical problem of making a decision in diagnosis for subjects with pulmonary nodules, we aimed to discover novel plasma protein biomarkers for lung adenocarcinoma (LUAD) and benign pulmonary nodules (BPNs) and then develop an integrative multianalytical model to guide the clinical management of LUAD and BPN patients. Through label-free quantitative plasma proteomic analysis (data are available via ProteomeXchange with identifier PXD046731), 12 differentially expressed proteins (DEPs) in LUAD and BPN were screened. The diagnostic abilities of DEPs were validated in two independent validation cohorts. The results showed that the levels of three candidate proteins (PRDX2, PON1, and APOC3) were lower in the plasma of LUAD than in BPN. The three candidate proteins were combined with three promising computed tomography indicators (spiculation, vascular notch sign, and lobulation) and three traditional markers (CEA, CA125, and CYFRA21-1) to construct an integrative multianalytical model, which was effective in distinguishing LUAD from BPN, with an AUC of 0.904, a sensitivity of 81.44%, and a specificity of 90.14%. Moreover, the model possessed impressive diagnostic performance between early LUADs and BPNs, with the AUC, sensitivity, specificity, and accuracy of 0.868, 65.63%, 90.14%, and 82.52%, respectively. This model may be a useful auxiliary diagnostic tool for LUAD and BPN by achieving a better balance of sensitivity and specificity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAdenocarcinoma of LungMultiple Pulmonary NodulesHumansProteomicsBiomarkersBlood ProteinsBiomarkers, TumorAryldialkylphosphataseAntigens, NeoplasmKeratin-19

Stichwörter der Autor:innen

benign pulmonary nodulesdifferential diagnosisintegrative multianalytical modellung adenocarcinomaplasma proteomics

Substanzen

BiomarkersBlood ProteinsBiomarkers, TumorAryldialkylphosphataseantigen CYFRA21.1Antigens, NeoplasmKeratin-19PON1 protein, human

Autor:innen und Institutionen

  • Department of Respiratory and Sleep Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052 Henan, China.
  • Henan Institute of Medical and Pharmaceutical Sciences & Henan Key Medical Laboratory of Tumor Molecular Biomarkers, Zhengzhou University, Zhengzhou 450001 Henan, China.
  • Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou 450052 Henan, China.
  • BGI College, Zhengzhou University, Zhengzhou 450001 Henan, China.
  • Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052 Henan, China.

ORCID-Profile: Liping Dai

Förderung

  • Natural Science Foundation of Henan Province
  • Leading Talents of Science and Technology Innovation in Henan Province

Zitieren

APA

Zhang, X., Ji, L., Liu, M., Li, J., Sun, H., Liang, F., Zhao, Y., Wang, Z., Yang, T., Wang, Y., Si, Q., Du, R., Dai, L., & Ouyang, S. (2024). Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing Lung Adenocarcinoma and Benign Pulmonary Nodules. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.3c00551

Vancouver

Zhang X, Ji L, Liu M, Li J, Sun H, Liang F, et al. Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing Lung Adenocarcinoma and Benign Pulmonary Nodules. Journal of Proteome Research. 2024. doi:10.1021/acs.jproteome.3c00551

BibTeX
@article{Zhang2024,
  author = {Zhang, Xue and Ji, Longtao and Liu, Man and Li, Jiaqi and Sun, Hao and Liang, Feifei and Zhao, Yutong and Wang, Zhi and Yang, Ting and Wang, Yulin and Si, Qiufang and Du, Renle and Dai, Liping and Ouyang, Songyun},
  title = {Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing Lung Adenocarcinoma and Benign Pulmonary Nodules},
  journal = {Journal of Proteome Research},
  year = {2024},
  doi = {10.1021/acs.jproteome.3c00551}
}
Kostenlos starten →